CTRI Number |
CTRI/2020/03/024119 [Registered on: 20/03/2020] Trial Registered Prospectively |
Last Modified On: |
01/11/2020 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
Public Title of Study
|
A clinical trial to study the effect of spinal morphine in reducing the requirement of locally anesthetizing drugs in labour analgesia |
Scientific Title of Study
|
Analgesic efficacy and Local anaesthetic sparing effect of intrathecal morphine as adjuvant to labor analgesia - A Double blinded prospective randomised controlled trial |
Trial Acronym |
RCT |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Rushil Vladimir |
Designation |
Junior resident |
Affiliation |
AIIMS , New Delhi |
Address |
Department of Anaesthesiology, Pain medicine and critical care room No- 5013, 5 Tth floor, teaching block, AIIMS, Ansari nagar, New Delhi
New Delhi DELHI 110029 India |
Phone |
9811461831 |
Fax |
|
Email |
rushilvladimir94@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Rajeshwari Subramaniam |
Designation |
Professor |
Affiliation |
AIIMS , New Delhi |
Address |
Department of Anaestheisology, Pain medicine and critical care, Room no-5011, 5 th floor teaching block, AIIMS, Ansari Nagar, New Delhi-110029
South DELHI 110029 India |
Phone |
09868397810 |
Fax |
|
Email |
drsrajeshwari@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Rushil Vladimir R |
Designation |
Junior resident |
Affiliation |
AIIMS , New Delhi |
Address |
Department of Anaestheisology, Pain medicine and critical care, Room no-5011, 5 th floor teaching block, AIIMS, Ansari Nagar, New Delhi..
South DELHI 110029 India |
Phone |
9811461831 |
Fax |
|
Email |
rushilvladimir94@gmail.com |
|
Source of Monetary or Material Support
|
AIIMS, Ansari nagar, New Delhi-110029 |
|
Primary Sponsor
|
Name |
AIIMS New Delhi |
Address |
AIIMS ,
New Delhi - 110023 |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
DrRushil Vladimir |
All India Institute if medical sciences |
Department of Anaestheisology, Pain medicine and critical care, Room no-5011, 5 th floor teaching block, AIIMS, Ansari Nagar, New Delhi-110029 New Delhi DELHI |
9811461831
rushilvladimir94@gmail.com |
|
Details of Ethics Committee
Modification(s)
|
No of Ethics Committees= 2 |
Name of Committee |
Approval Status |
AIIMS ethics |
Approved |
Ethics committee fo postgraduate research ,AIIMS |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Healthy Human Volunteers |
Pregnancy - labour pain |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Group M -Intrathecal morphine |
Drug - Intrathecal morphine 250 mcgs + Bupivaciane 2 mg + Fentanyl 25 mcgs at the onset of labour pain followed by epidural catheterisation and epidiral analgesia will be provided till postnatal period of 24 hours. |
Comparator Agent |
Intrathecal saline |
Drug - Intrathecal normal saline 0.25 ml + Bupivaciane 2 mg + Fentanyl 25 mcgs at the onset of labour pain followed by epidural catheterisation and epidural analgesia will be provided till postnatal period of 24 hours. |
|
Inclusion Criteria
|
Age From |
20.00 Year(s) |
Age To |
35.00 Year(s) |
Gender |
Female |
Details |
1.ASA I and II
2.Primi gravida/ Mutigravida, para 0
3.Uncomplicated singleton pregnancy
4.Vertex presentation
5.Active labour
6.Requesting for labour analgesia
|
|
ExclusionCriteria |
Details |
- Local or systemic infection
- Patient not willing to participate
- Known allergy to study drugs
- Bleeding disorders
- Decreased platelet counts
- Usage of opioids/other analgesics in last 4hours |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant and Investigator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Effect of intrathecal morphine on Local anaesthetic requirement epidurally during labour |
Every 30 minutes till delivery, then every 6 hours postnatal till 24 hours. |
|
Secondary Outcome
|
Outcome |
TimePoints |
Effect of intrathecal morphine on
1. Pain scores by VAS in I, II and III stages of labour
2.Incidence of maternal nausea and vomiting , urinary retention and pruritus
3.Rate of instrumental delivery
4.APGAR scores at 1 , 2 and 5 minutes
5. Maternal satisfaction (assessed by a subjective scale)
|
Every 30 minutes till delivery and then postnatal every 6 hours for 24 hours. |
|
Target Sample Size
|
Total Sample Size="70" Sample Size from India="70"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
23/03/2020 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="2" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
Modification(s)
|
None yet |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
A double blinded RCT on the analgesic efficacy and local anesthetic sapring effect of intrathecal morphine as adjunct for labour analgesia . Patients will be allocated to one of the two groups. Group M- Patients who will receive intrathecal morphine 250 μg along with bupivacaine 2 mg and fentanyl 25 μg Group F- Patients who will receive normal saline (0.25 ml) along with bupivacaine 2mg and fentanyl 25μg
|